Patents by Inventor Shai Rosenwald

Shai Rosenwald has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Gene Expression Signature for Classification of Tissue of Origin of Tumor Samples
    Publication number: 20190241966
    Abstract: The present invention provides a process for classification of cancers and tissues of origin through the analysis of the expression patterns of specific microRNAs and nucleic acid molecules relating thereto. Classification according to a microRNA tree-based expression framework allows optimization of treatment, and determination of specific therapy.
    Type: Application
    Filed: December 19, 2018
    Publication date: August 8, 2019
    Applicant: Rosetta Genomics Ltd.
    Inventors: Ranit Aharonov, Nitzan Rosenfeld, Shai Rosenwald
  • METHODS AND MATERIALS FOR CLASSIFICATION OF TISSUE OF ORIGIN OF TUMOR SAMPLES
    Publication number: 20190032142
    Abstract: The present invention provides a process for classification of cancers and tissues of origin through the analysis of the expression patterns of specific microRNAs and nucleic acid molecules relating thereto. Classification according to a microRNA tree-based expression framework allows optimization of treatment, and determination of specific therapy.
    Type: Application
    Filed: March 1, 2018
    Publication date: January 31, 2019
    Applicant: Rosetta Genomics Ltd.
    Inventors: Ranit Aharonov, Nitzan Rosenfeld, Shai Rosenwald, Nir Dromi
  • GENE EXPRESSION SIGNATURE FOR CLASSIFICATION OF TISSUE OF ORIGIN OF TUMOR SAMPLES
    Publication number: 20180127835
    Abstract: The present invention provides a process for classification of cancers and tissues of origin through the analysis of the expression patterns of specific microRNAs and nucleic acid molecules relating thereto. Classification according to a microRNA tree-based expression framework allows optimization of treatment, and determination of specific therapy.
    Type: Application
    Filed: December 22, 2017
    Publication date: May 10, 2018
    Applicant: Rosetta Genomics Ltd.
    Inventors: Ranit Aharonov, Nitzan Rosenfeld, Shai Rosenwald
  • MicroRNAs expression signature for determination of tumors origin
    Patent number: 9803247
    Abstract: The present invention provides a process for classification of specific cancers and tumors origin through the analysis of the expression patterns of specific microRNAs and nucleic acid molecules relating thereto. Classification according to a microRNA expression framework allows optimization of treatment, and determination of specific therapy.
    Type: Grant
    Filed: May 21, 2014
    Date of Patent: October 31, 2017
    Assignees: Rosetta Genomics, Ltd., Tel Hashomer Medical Infrastructure and Services Ltd.
    Inventors: Nitzan Rosenfeld, Shai Rosenwald, Iris Barshack, Dvora Nass
  • MICRORNAS EXPRESSION SIGNATURE FOR DETERMINATION OF TUMORS ORIGIN
    Publication number: 20160115546
    Abstract: The present invention provides a process for classification of specific cancers and tumors origin through the analysis of the expression patterns of specific microRNAs and nucleic acid molecules relating thereto. Classification according to a microRNA expression framework allows optimization of treatment, and determination of specific therapy.
    Type: Application
    Filed: May 21, 2014
    Publication date: April 28, 2016
    Inventors: Nitzan ROSENFELD, Shai Rosenwald, Iris Barshack, Dvora Nass
  • Compositions and methods for prognosis and treatment of prostate cancer
    Patent number: 9243296
    Abstract: Described herein are compositions and methods for prognosis and treatment of prostate cancer patients. Specifically the invention relates to microRNA molecules associated with the prognosis of prostate cancer, as well as various nucleic acid molecules relating thereto or derived therefrom.
    Type: Grant
    Filed: July 30, 2014
    Date of Patent: January 26, 2016
    Assignee: Rosetta Genomics Ltd.
    Inventors: Ayelet Chajut, Shai Rosenwald
  • METHODS AND MATERIALS FOR CLASSIFICATION OF TISSUE OF ORIGIN OF TUMOR SAMPLES
    Publication number: 20150368724
    Abstract: The present invention provides a process for classification of cancers and tissues of origin through the analysis of the expression patterns of specific microRNAs and nucleic acid molecules relating thereto. Classification according to a microRNA tree-based expression framework allows optimization of treatment, and determination of specific therapy.
    Type: Application
    Filed: June 22, 2015
    Publication date: December 24, 2015
    Inventors: Ranit Aharonov, Nitzan Rosenfeld, Shai Rosenwald, Nir Dromi
  • Compositions and methods for the diagnosis and prognosis of mesothelioma
    Patent number: 9133522
    Abstract: The present invention provides nucleic acid sequences that are used for identification and diagnosis of specific cancers. The nucleic acid sequences can also be used for prognosis evaluation of a subject based on the expression profile of a biological sample.
    Type: Grant
    Filed: October 29, 2008
    Date of Patent: September 15, 2015
    Assignee: Rosetta Genomics Ltd.
    Inventors: Shai Rosenwald, Hila Benjamin, Nitzan Rosenfeld
  • Gene expression signature for classification of tissue of origin of tumor samples
    Patent number: 9096906
    Abstract: The present invention provides a process for classification of cancers and tissues of origin through the analysis of the expression patterns of specific microRNAs and nucleic acid molecules relating thereto. Classification according to a microRNA tree-based expression framework allows optimization of treatment, and determination of specific therapy.
    Type: Grant
    Filed: April 3, 2013
    Date of Patent: August 4, 2015
    Assignee: Rosetta Genomics Ltd.
    Inventors: Ranit Aharonov, Nitzan Rosenfeld, Shai Rosenwald, Nir Dromi
  • Gene expression signature for classification of kidney tumors
    Patent number: 9068232
    Abstract: The present invention provides a method for classification of kidney tumors through the analysis of the expression patterns of specific microRNAs and nucleic acid molecules relating thereto. Classification according to a microRNA expression framework allows optimization of treatment, and determination of specific therapy.
    Type: Grant
    Filed: March 5, 2012
    Date of Patent: June 30, 2015
    Assignees: Rosetta Genomics Ltd., Tel Hashomer Medical Research Infrastructure and Services Ltd.
    Inventors: Nitzan Rosenfeld, Yael Spector, Eddie Friedman, Zohar Dotan, Shai Rosenwald
  • METHODS FOR DISTINGUISHING BETWEEN SPECIFIC TYPES OF LUNG CANCERS
    Publication number: 20150099665
    Abstract: The present invention provides nucleic acid sequences that are used for identification, classification and diagnosis of lung cancers. The present invention further provides microRNA molecules, as well as various nucleic acid molecules relating thereto or derived therefrom, associated with specific types of lung cancers.
    Type: Application
    Filed: December 16, 2014
    Publication date: April 9, 2015
    Applicants: ROSETTA GENOMICS LTD., TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.
    Inventors: Nitzan Rosenfeld, Shai Rosenwald, Iris Barshack, Gila Lithwick Yanai
  • COMPOSITIONS AND METHODS FOR PROGNOSIS AND TREATMENT OF PROSTATE CANCER
    Publication number: 20140336241
    Abstract: Described herein are compositions and methods for prognosis and treatment of prostate cancer patients. Specifically the invention relates to microRNA molecules associated with the prognosis of prostate cancer, as well as various nucleic acid molecules relating thereto or derived therefrom.
    Type: Application
    Filed: July 30, 2014
    Publication date: November 13, 2014
    Applicant: ROSETTA GENOMICS LTD.
    Inventors: Ayelet CHAJUT, Shai ROSENWALD
  • GENE EXPRESSION SIGNATURE FOR CLASSIFICATION OF TISSUE OF ORIGIN OF TUMOR SAMPLES
    Publication number: 20140315739
    Abstract: The present invention provides a process for classification of cancers and tissues of origin through the analysis of the expression patterns of specific microRNAs and nucleic acid molecules relating thereto. Classification according to a microRNA tree-based expression framework allows optimization of treatment, and determination of specific therapy.
    Type: Application
    Filed: June 30, 2014
    Publication date: October 23, 2014
    Applicant: ROSETTA GENOMICS LTD.
    Inventors: Ranit Aharonov, Nitzan Rosenfeld, Shai Rosenwald
  • Compositions and methods for prognosis and treatment of prostate cancer
    Patent number: 8822144
    Abstract: Described herein are compositions and methods for prognosis and treatment of prostate cancer patients. Specifically the invention relates to microRNA molecules associated with the prognosis of prostate cancer, as well as various nucleic acid molecules relating thereto or derived therefrom.
    Type: Grant
    Filed: July 20, 2010
    Date of Patent: September 2, 2014
    Assignee: Rosetta Genomics Ltd.
    Inventors: Ayelet Chajut, Shai Rosenwald
  • Gene expression signature for classification of tissue of origin of tumor samples
    Patent number: 8802599
    Abstract: The present invention provides a process for classification of cancers and tissues of origin through the analysis of the expression patterns of specific microRNAs and nucleic acid molecules relating thereto. Classification according to a microRNA tree-based expression framework allows optimization of treatment, and determination of specific therapy.
    Type: Grant
    Filed: June 23, 2011
    Date of Patent: August 12, 2014
    Assignee: Rosetta Genomics, Ltd.
    Inventors: Ranit Aharonov, Nitzan Rosenfeld, Shai Rosenwald
  • Methods for distinguishing between lung squamous carcinoma and other non small cell lung cancers
    Patent number: 8563252
    Abstract: The present invention provides nucleic acid sequences that are used for identification, classification and diagnosis of specific types of nonsmall-cell lung cancers (NSCLC). The nucleic acid sequences can also be used for prognosis evaluation of a subject based on the expression pattern of a biological sample.
    Type: Grant
    Filed: August 31, 2009
    Date of Patent: October 22, 2013
    Assignee: Rosetta Genomics Ltd.
    Inventors: Ranit Aharonov, Nitzan Rosenfeld, Shai Rosenwald, Hila Benjamin
  • GENE EXPRESSION SIGNATURE FOR CLASSIFICATION OF TISSUE OF ORIGIN OF TUMOR SAMPLES
    Publication number: 20130259839
    Abstract: The present invention provides a process for classification of cancers and tissues of origin through the analysis of the expression patterns of specific microRNAs and nucleic acid molecules relating thereto. Classification according to a microRNA tree-based expression framework allows optimization of treatment, and determination of specific therapy.
    Type: Application
    Filed: April 3, 2013
    Publication date: October 3, 2013
    Inventors: Ranit AHARONOV, Nitzan ROSENFELD, Shai ROSENWALD, Nir DROMI
  • COMPOSITIONS AND METHODS FOR PROGNOSIS AND TREATMENT OF PROSTATE CANCER
    Publication number: 20120232124
    Abstract: Described herein are compositions and methods for prognosis and treatment of prostate cancer patients. Specifically the invention relates to microRNA molecules associated with the prognosis of prostate cancer, as well as various nucleic acid molecules relating thereto or derived therefrom.
    Type: Application
    Filed: July 20, 2010
    Publication date: September 13, 2012
    Applicant: Rosetta Genomics Lts
    Inventors: Ayelet Chajut, Shai Rosenwald
  • GENE EXPRESSION SIGNATURE FOR CLASSIFICATION OF KIDNEY TUMORS
    Publication number: 20120157344
    Abstract: The present invention provides a method for classification of kidney tumors through the analysis of the expression patterns of specific microRNAs and nucleic acid molecules relating thereto. Classification according to a microRNA expression framework allows optimization of treatment, and determination of specific therapy.
    Type: Application
    Filed: March 5, 2012
    Publication date: June 21, 2012
    Inventors: NITZAN ROSENFELD, YAEL SPECTOR, EDDIE FRIEDMAN, ZOHAR DOTAN, SHAI ROSENWALD
  • GENE EXPRESSION SIGNATURE FOR CLASSIFICATION OF TISSUE OF ORIGIN OF TUMOR SAMPLES
    Publication number: 20110312530
    Abstract: The present invention provides a process for classification of cancers and tissues of origin through the analysis of the expression patterns of specific microRNAs and nucleic acid molecules relating thereto. Classification according to a microRNA tree-based expression framework allows optimization of treatment, and determination of specific therapy.
    Type: Application
    Filed: June 23, 2011
    Publication date: December 22, 2011
    Inventors: Ranit AHARONOV, Nitzan Rosenfeld, Shai Rosenwald